{
    "clinical_study": {
        "@rank": "77068", 
        "arm_group": [
            {
                "arm_group_label": "KCT-0809 ophtalmic solution", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to\n      placebo in patients with dry eye syndromes."
        }, 
        "brief_title": "A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes", 
        "condition": "Dry Eye Syndromes", 
        "condition_browse": {
            "mesh_term": [
                "Dry Eye Syndromes", 
                "Keratoconjunctivitis Sicca"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Corneal and conjunctival damage\n\n          -  Insufficiency of lacrimal secretion\n\n          -  Ocular symptom\n\n        Exclusion Criteria:\n\n          -  Severe ophthalmic disorder\n\n          -  Punctual plugs or surgery for occlusion of the lacrimal puncta"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "firstreceived_date": "September 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01692145", 
            "org_study_id": "KCT1204"
        }, 
        "intervention": [
            {
                "arm_group_label": "KCT-0809 ophtalmic solution", 
                "intervention_name": "KCT-0809", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "keyword": [
            "Dry eye syndromes", 
            "Corneal diseases", 
            "Conjunctival diseases"
        ], 
        "lastchanged_date": "May 29, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tokyo and Other Japanese City", 
                    "country": "Japan"
                }, 
                "name": "Japan"
            }
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_outcome": {
            "measure": "Score of the Corneal conjunctival staining", 
            "safety_issue": "No"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01692145"
        }, 
        "source": "Kissei Pharmaceutical Co., Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kissei Pharmaceutical Co., Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}